Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Frank Brisebois who wrote (8164)	7/26/1999 10:09:00 AM
From: Mark S.	Respond to of 9523

Systematic risk

To: Frank Brisebois who wrote (8164)	7/26/1999 11:59:00 PM
From: J. P.	Read Replies (2) \| Respond to of 9523

Long term, you're sure to make money here. This is no tech stock. Market is retracing, gonna drag Pfizer down with it for a while, although the downside risk seems minimal. Could make a case for overvaluation, but this is a great company, with some great products. But I said it before and I'll say it again, the last earnings announcement was incredibly botched by management. I've seen this before when management decides they're too smart to play footsie with Wall Street. They have to remember this is a publicly traded company no matter how big, and their duty is not to their own galactic sized egos, but to the shareholders. Hope they learned something, but somehow I doubt it.